Roger D Tung - Net Worth and Insider Trading
Roger D Tung Net Worth
The estimated net worth of Roger D Tung is at least $9 Million dollars as of 2024-09-20. Roger D Tung is the CEO of Concert Pharmaceuticals Inc and owns about 1,118,554 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $9 Million. Details can be seen in Roger D Tung's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Roger D Tung has not made any transactions after 2023-01-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Roger D Tung
Roger D Tung Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Roger D Tung owns 2 companies in total, including Concert Pharmaceuticals Inc (CNCE) , and Salarius Pharmaceuticals Inc (SLRX) .
Click here to see the complete history of Roger D Tung’s form 4 insider trades.
Insider Ownership Summary of Roger D Tung
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CNCE | Concert Pharmaceuticals Inc | 2023-01-06 | director & Chief Executive Officer |
SLRX | Salarius Pharmaceuticals Inc | 2017-10-30 | director |
Roger D Tung Latest Holdings Summary
Roger D Tung currently owns a total of 1 stock. Roger D Tung owns 1,118,554 shares of Concert Pharmaceuticals Inc (CNCE) as of January 6, 2023, with a value of $9 Million.
Latest Holdings of Roger D Tung
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CNCE | Concert Pharmaceuticals Inc | 2023-01-06 | 1,118,554 | 8.37 | 9,362,297 |
Holding Weightings of Roger D Tung
Roger D Tung Form 4 Trading Tracker
According to the SEC Form 4 filings, Roger D Tung has made a total of 3 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Concert Pharmaceuticals Inc is the sale of 9,240 shares on January 6, 2023, which brought Roger D Tung around $66,898.
Insider Trading History of Roger D Tung
- 1
Roger D Tung Trading Performance
GuruFocus tracks the stock performance after each of Roger D Tung's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Roger D Tung is 4.36%. GuruFocus also compares Roger D Tung's trading performance to market benchmark return within the same time period. The performance of stocks bought by Roger D Tung within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Roger D Tung's insider trading performs compared to the benchmark.
Performance of Roger D Tung
Roger D Tung Ownership Network
Roger D Tung Owned Company Details
What does Concert Pharmaceuticals Inc do?
Who are the key executives at Concert Pharmaceuticals Inc?
Roger D Tung is the director & Chief Executive Officer of Concert Pharmaceuticals Inc. Other key executives at Concert Pharmaceuticals Inc include Chief Development Officer James V Cassella , CFO & PFO Marc A. Becker , and Chief Operating Officer Nancy Stuart .
Concert Pharmaceuticals Inc (CNCE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Concert Pharmaceuticals Inc Insider Transactions
Roger D Tung Mailing Address
Above is the net worth, insider trading, and ownership report for Roger D Tung. You might contact Roger D Tung via mailing address: 99 Hayden Avenue, Suite 500, Lexington Ma 02421.